IL84312A - Ifosfamide lyophilisate and its preparation - Google Patents
Ifosfamide lyophilisate and its preparationInfo
- Publication number
- IL84312A IL84312A IL84312A IL8431287A IL84312A IL 84312 A IL84312 A IL 84312A IL 84312 A IL84312 A IL 84312A IL 8431287 A IL8431287 A IL 8431287A IL 84312 A IL84312 A IL 84312A
- Authority
- IL
- Israel
- Prior art keywords
- ifosfamide
- preparation
- lyophilisate
- ifosfamide lyophilisate
- weight
- Prior art date
Links
- HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001101 ifosfamide Drugs 0.000 title abstract 3
- FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical compound OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Amplifiers (AREA)
- Control Of El Displays (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3637089 | 1986-10-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL84312A0 IL84312A0 (en) | 1988-03-31 |
| IL84312A true IL84312A (en) | 1991-11-21 |
Family
ID=6312873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL84312A IL84312A (en) | 1986-10-31 | 1987-10-29 | Ifosfamide lyophilisate and its preparation |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0265812B1 (enEXAMPLES) |
| JP (1) | JPS63159319A (enEXAMPLES) |
| KR (1) | KR900003491B1 (enEXAMPLES) |
| AT (1) | ATE55250T1 (enEXAMPLES) |
| AU (1) | AU598602B2 (enEXAMPLES) |
| CA (1) | CA1314231C (enEXAMPLES) |
| DD (1) | DD262582A5 (enEXAMPLES) |
| DE (1) | DE3764235D1 (enEXAMPLES) |
| DK (1) | DK169308B1 (enEXAMPLES) |
| EG (1) | EG18333A (enEXAMPLES) |
| ES (1) | ES2017982B3 (enEXAMPLES) |
| FI (1) | FI87140C (enEXAMPLES) |
| GE (1) | GEP19971025B (enEXAMPLES) |
| GR (1) | GR3000708T3 (enEXAMPLES) |
| HU (1) | HU197987B (enEXAMPLES) |
| IL (1) | IL84312A (enEXAMPLES) |
| IN (1) | IN168119B (enEXAMPLES) |
| LV (1) | LV10051B (enEXAMPLES) |
| MX (1) | MX8958A (enEXAMPLES) |
| NO (1) | NO873860L (enEXAMPLES) |
| PT (1) | PT86032B (enEXAMPLES) |
| RU (1) | RU1836079C (enEXAMPLES) |
| UA (1) | UA11075A (enEXAMPLES) |
| YU (1) | YU197387A (enEXAMPLES) |
| ZA (1) | ZA878183B (enEXAMPLES) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0334083B1 (de) * | 1988-03-19 | 1991-07-24 | ASTA Pharma Aktiengesellschaft | Ifosfamid-Mesna-Lyophilisat und Verfahren zu dessen Herstellung |
| US5227373A (en) * | 1991-10-23 | 1993-07-13 | Bristol-Myers Squibb Co. | Lyophilized ifosfamide compositions |
| WO1995007083A1 (en) * | 1993-09-10 | 1995-03-16 | F.H. Faulding & Co. Limited | Ifosfamide lyophilisate composition |
| DE19529057B4 (de) * | 1995-08-08 | 2007-12-13 | Baxter Healthcare S.A. | Ifosfamid-Lyophilisat-Zubereitungen |
| AU757002B2 (en) * | 1998-03-03 | 2003-01-30 | Eli Lilly And Company | Pharmaceutical compositions containing the phospholipase inhibitor sodium ((3-(2-amino-1,2-dioxoethyl)-2-ethyl-1- phenylmethyl)-1H-indol-4-YL)oxy)acetate |
| NZ538584A (en) * | 2002-09-05 | 2007-05-31 | Bharat Serums & Vaccines Ltd | Stable liquid composition of oxazaphosphorine, mesna and etherified beta-cyclodextrin |
| AU2003302579B2 (en) * | 2002-12-02 | 2008-09-18 | Bharat Serums And Vaccines Ltd. | Ifosfamide compositions for parenteral administration and a process for their preparation |
| US8436190B2 (en) * | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| BRPI0715279A2 (pt) * | 2006-09-29 | 2013-06-11 | Infa Sa | sistema de embalagem, sistema de embalagem para uma composiÇço farmacÊutica, mÉtodo para transferir uma composiÇço farmcÊutica para administraÇço por infusço intravenosa, uso de um sistema de embalagem, kit para administraÇço parenteral de fÁrmacos com um acesso intravenoso e kit admnistraÇço parenteral de princÍpios ativos |
| WO2016087001A1 (en) * | 2014-12-04 | 2016-06-09 | Huawei Technologies Co., Ltd. | Load allocation in a data communication network |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3732340A (en) * | 1966-07-11 | 1973-05-08 | Asta Werke Ag Chem Fab | N',o-propylene phosphoric acid ester diamides |
| DE2750207A1 (de) * | 1977-05-09 | 1978-11-16 | Walton J Smith | Gefriergetrocknete zusammensetzungen, insbesondere gefriergetrocknete pharmazeutische praeparate und verfahren zu deren herstellung |
| EP0083439B1 (de) * | 1981-12-31 | 1989-07-26 | ASTA Pharma AG | 4-Sulfido-oxazaphosphorine und deren Verwendung bei der Krebsbekämpfung und zur Immunsuppression |
| US4537883A (en) * | 1982-11-12 | 1985-08-27 | Mead Johnson & Company | Lyophilized cyclophosphamide |
-
1987
- 1987-09-15 NO NO873860A patent/NO873860L/no unknown
- 1987-10-20 DE DE8787115322T patent/DE3764235D1/de not_active Expired - Lifetime
- 1987-10-20 ES ES87115322T patent/ES2017982B3/es not_active Expired - Lifetime
- 1987-10-20 EP EP87115322A patent/EP0265812B1/de not_active Expired - Lifetime
- 1987-10-20 AT AT87115322T patent/ATE55250T1/de not_active IP Right Cessation
- 1987-10-23 MX MX895887A patent/MX8958A/es unknown
- 1987-10-26 IN IN837/CAL/87A patent/IN168119B/en unknown
- 1987-10-27 FI FI874727A patent/FI87140C/fi not_active IP Right Cessation
- 1987-10-28 EG EG61687A patent/EG18333A/xx active
- 1987-10-29 IL IL84312A patent/IL84312A/xx not_active IP Right Cessation
- 1987-10-29 PT PT86032A patent/PT86032B/pt unknown
- 1987-10-29 JP JP62272002A patent/JPS63159319A/ja active Granted
- 1987-10-29 RU SU874203570A patent/RU1836079C/ru active
- 1987-10-29 UA UA4203570A patent/UA11075A/uk unknown
- 1987-10-30 KR KR1019870012077A patent/KR900003491B1/ko not_active Expired
- 1987-10-30 DD DD87308471A patent/DD262582A5/de not_active IP Right Cessation
- 1987-10-30 DK DK569687A patent/DK169308B1/da not_active IP Right Cessation
- 1987-10-30 YU YU01973/87A patent/YU197387A/xx unknown
- 1987-10-30 AU AU80529/87A patent/AU598602B2/en not_active Ceased
- 1987-10-30 ZA ZA878183A patent/ZA878183B/xx unknown
- 1987-10-30 HU HU874900A patent/HU197987B/hu unknown
- 1987-10-30 CA CA000550706A patent/CA1314231C/en not_active Expired - Lifetime
-
1990
- 1990-08-09 GR GR90400533T patent/GR3000708T3/el unknown
-
1992
- 1992-10-27 LV LVP-92-174A patent/LV10051B/lv unknown
-
1993
- 1993-07-07 GE GEAP1993972A patent/GEP19971025B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0348808A3 (de) | Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung | |
| GB8712073D0 (en) | Medicament | |
| EP0427247A3 (en) | Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient | |
| EP0196524A3 (en) | Phenoxyalkylaminopyrimidine derivatives, their preparation and insecticidal and acaricidal compositions containing them | |
| GR3002377T3 (en) | Ifosfamide-mesna-lyophilized composition and process to prepare it | |
| HUT44438A (en) | Composition comprising l-dopa | |
| PH23565A (en) | Novel pyrimidinylpyrimidine derivatives and a plant disease protectant containing them as the active ingredient | |
| IL86798A (en) | 2,2-dimethylchroman-3-ol derivatives, their preparation and pharmaceutical compositions containing them | |
| IL84312A0 (en) | Ifosfamide lyophilisate and its preparation | |
| IL81602A0 (en) | Substituted 1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acids,their preparation and pharmaceutical compositions containing them | |
| IL83412A (en) | 5',5'-disubstituted 2',5'-dideoxyuridines and 2',5'-dideoxycytidines,their preparation and pharmaceutical compositions containing them | |
| ZA886107B (en) | Antiviral preparation | |
| IL85189A (en) | Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them | |
| IL84551A (en) | Peptides,their preparation and pharmaceutical compositions containing them | |
| IL82145A0 (en) | Substituted thiacycloalkeno(3,2-b)pyridines,their preparation and pharmaceutical compositions containing them | |
| KR900700484A (ko) | 1,4:3,6-디안히드로 헥시톨 잘산염의 아미노프로판올 유도체,그의 제법 및 약제로서의 그의 용도 | |
| IL85651A0 (en) | Optically active oxo-isoindolinyl derivatives,their preparation and pharmaceutical compositions containing them | |
| OA09419A (fr) | Dérivés de l'acide 3-pyrrolidinylthio-1-azabicyclo (3.2.0.) -hept-2-ene-2-carboxylique et leur préparation. | |
| IL87173A (en) | 4-heterocyclyl thio-phenyl-thiourea,isothiourea and/or carbodiimide derivatives,their preparation and insecticidal and acaricidal compositions containing them | |
| IL83370A0 (en) | Preparation of 3,4-diamino-5-benzylpyrimidines | |
| IL88849A0 (en) | Preparation of 1,5-benzo-thiazepine derivatives | |
| IL89631A0 (en) | Preparation of 2,6-dioxopiperidine derivatives | |
| IL83606A0 (en) | Derivatives of 2,2-dimethyl-cyclopropanecarboxylic acid,their preparation and their use as insecticides and acaricides | |
| IL85856A0 (en) | Tert.-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2,its acid addition salts and pharmaceutical compositions containing them | |
| IL82570A0 (en) | Preparation of 3,4-dimethoxy-phenylacetone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |